“Patient and Parent/Caregiver Satisfaction with Efficacy and Cosmetic Elegance of Tapinarof Cream 1% Once Daily in a Long-term Extension Trial in Adults and Children Down to Age 2 Years with Atopic Dermatitis”, J of Skin, vol. 8, no. 6, p. s458, Nov. 2024, doi: 10.25251/skin.8.supp.458.